The diagnostic accuracy of Fibroscan® for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response

Journal of Hepatology

Volumn 59, Issue 2, 2013, Pages 251-256

  D'Ambrosio, Roberta ^a,b   Aghemo, Alessio ^a   Fraquelli, Mirella ^a   Rumi, Maria Grazia ^a   Donato, Maria Francesca ^a   Paradis, Valerie ^b   Bedossa, Pierre ^b   Colombo, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

Cirrhosis regression; Fibroscan ; Hepatitis C virus; Morphometry; Sustained virological response

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELASTOGRAPHY; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER STRUCTURE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TRANSIENT ELASTOGRAPHY;

CI; CIRRHOSIS REGRESSION; CONFIDENCE INTERVAL; FIBROSCAN®; HBV; HCV; HEPATITIS B VIRUS; HEPATITIS C VIRUS; IFN; INTERFERON; INTERQUARTILE RATIO; IQR; LB; LIKELIHOOD RATIO; LIVER BIOPSY; LIVER STIFFNESS; LIVER STIFFNESS MEASUREMENT; LR; LS; LSM; MORPHOMETRY; RBV; RIBAVIRIN; SUSTAINED VIROLOGICAL RESPONSE; SVR; TE; TRANSIENT ELASTOGRAPHY;

AGED; ANTIVIRAL AGENTS; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PILOT PROJECTS;

EID: 84880317615     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.03.013     Document Type: Article

References (42)

1. O. Reichard, H. Glaumann, A. Fryden, G. Norkrans, R. Wejstal, and O. Weiland Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon J Hepatol 30 1999 783 787
2. Y. Shiratori, F. Imazeki, M. Moryiama, M. Yano, Y. Arakawa, and O. Yokosuka Histological improvement of fibrosis in patients with hepatitis C who have sustained virological response to interferon therapy Ann Intern Med 132 2000 517 524
3. A. Arif, R.A. Levine, S.O. Sanderson, L. Bank, R.P. Velu, and A. Shah Regression of fibrosis in chronic hepatitis C after therapy with interferon and ribavirin Dig Dis Sci 48 2003 1425 1430
4. S. Pol, F. Carnot, B. Nalpas, J.L. Lagneau, H. Fontaine, and J. Serpaggi Reversibility of hepatitis C virus-related cirrhosis Hum Pathol 35 2004 107 112
5. V. Mallet, H. Gilgenkrantz, J. Serpaggi, V. Verkarre, A. Vallet-Pichard, and H. Fontaine Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C Ann Intern Med 149 2008 399 403
6. S.L. George, B.R. Bacon, E.M. Brunt, K.L. Mihindukulasuriya, J. Hoffmann, and A.M. Di Bisceglie Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy Hepatology 49 2009 729 738
7. R. D'Ambrosio, A. Aghemo, M.G. Rumi, G. Ronchi, M.F. Donato, and V. Paradis A morphometric and immunohistochemical study to assess the benefit of a SVR in HCV cirrhotic patients Hepatology 56 2012 532 543
8. J.L. Dienstag, R.D. Goldin, E.J. Heathcote, H.W.L. Hann, M. Woessner, and S.L. Stephenson Histological outcome during long-term lamivudine therapy Gastroenterology 124 2003 105 117
9. T.T. Chang, Y.F. Liaw, S.S. Wu, E.R. Schiff, K.H. Han, and C.L. Lai Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B Hepatology 52 2010 886 893
10. P. Marcellin, M. Buti, and E.J. Gane Five years of treatment with tenofovir DF for chronic hepatitis B infection is associated with sustained viral suppression and significant regression of histological fibrosis and cirrhosis Hepatology 54 2011 1011A 1012A
11. F. Piccinino, E. Sagnelli, G. Pasquale, and G. Giusti Complications following percutaneous liver biopsy. A multicentre retrospective study on 68.276 biopsies J Hepatol 2 1986 165 173
12. A.A. Bravo, S.G. Sheth, and S. Chopra Liver biopsy N Engl J Med 344 2001 495 500
13. M.C. Rousselet, S. Michalak, F. Dupré, A. Croué, P. Bedossa, and J.P. Saint-André Sources of variability in histological scoring of chronic viral hepatitis Hepatology 41 2005 257 264
14. P. Bedossa, D. Dargère, and V. Paradis Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 2003 1449 1457
15. B. Maharaj, R.J. Maharaj, W.P. Leary, R.M. Cooppan, A.D. Naran, and D. Pirie Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver Lancet 1 1986 523 525
16. G. Colloredo, M. Guido, A. Sonzogni, and G. Leandro Impact of liver biopsy size on histological evaluation of chronic viral epatiti: the smaller the sample, the milder the disease J Hepatol 15 2003 959 966
17. The French METAVIR Cooperative Study Group Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C Hepatology 20 1994 15 20
18. L. Castera, L. Vergniol, J. Foucher, B. Le Bail, E. Chanteloup, and M. Haaser Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 2005 343 350
19. M. Ziol, A. Handra-Luca, A. Kettaneh, C. Christidis, F. Mal, and F. Kazemi Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C Hepatology 41 2005 48 54
20. N. Ganne-Carriè, M. Ziol, V. de Ledinghen, C. Douvin, P. Marcellin, and L. Castera Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases Hepatology 44 2006 1511 1517
21. J. Foucher, E. Chanteloup, J. Vergniol, L. Castéra, B. Le Bail, and X. Adhoute Diagnosis of cirrhosis by transient elastography (Fibroscan®): a prospective study Gut 55 2006 403 408
22. M. Fraquelli, C. Rigamonti, G. Casazza, D. Conte, M.F. Donato, and G. Ronchi Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease Gut 56 2007 698 973
23. European Association of the Study of the Liver EASL Practice Guidelines: management of hepatitis C virus infection J Hepatol 55 2011 245 264
24. P. Bedossa, and T. Poynard An alghoritm for the grading of activity in chronic hepatitis C Hepatology 24 1996 289 293
25. K. Ishak, A. Baptista, L. Bianchi, F. Callea, J. De Groote, and F. Gudat Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
26. L. Sandrin, B. Fourquet, J.M. Hasquenoph, S. Yon, C. Fournier, and F. Mal Transient elastography: a new noninvasive method for assessment of hepatic fibrosis Ultrasound Med Biol 29 2003 1705 1713
27. L. Castera Non invasive methods to assess liver disease in patients with hepatitis B or C Gastroenterology 142 2012 1293 1302
28. P.P. Anthony, K.G. Ishak, N.C. Nayak, H.E. Poulsen, P.J. Scheuer, and L.H. Sobin The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the Word Health Organization J Clin Pathol 31 1978 395 414
29. S. Gaia, S. Carenzi, A.L. Barilli, E. Bugianesi, A. Smedile, and F. Brunello Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis J Hepatol 54 2001 64 71
30. M. Ziol, A. Kettaneh, N. Ganne-Carrié, N. Barget, I. Tengher-Barna, and M. Beaugrand Relationships between fibrosis amounts assessed by morphometry and liver stiffness measurements in chronic hepatitis or steatohepatitis Eur J Gastroenterol Hepatol 21 2009 1261 1268
31. B. Coco, F. Oliveri, A.M. Maina, P. Ciccorossi, R. Sacco, and P. Colombatto Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases J Viral Hepat 14 2007 360 369
32. A. Sagir, A. Erhardt, M. Schmitt, and D. Häussinger Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage Hepatology 47 2008 592 595
33. U. Arena, F. Vizzutti, G. Corti, S. Ambu, C. Stasi, and S. Bresci Acute viral hepatitis increases liver stiffness values measured by transient elastography Hepatology 47 2008 380 384
34. M. Viganò, S. Massironi, P. Lampertico, M. Iavarone, S. Paggi, and R. Pozzi Transient elastography assessment of the liver stiffness dynamics during acute hepatitis B Eur J Gastroenterol Hepatol 22 2010 180 184
35. E. Vispo, P. Barreiro, J. Del Valle, I. Maida, V. de Ledinghen, and C. Quereda Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation Antiviral Ther 14 2009 187 193
36. J.H. Wang, C.S. Changchien, C.H. Hung, W.C. Tung, K.M. Kee, and C.H. Chen Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: longitudinal study using Fibroscan® J Gastroenterol Hepatol 25 2010 964 969
37. Y. Arima, N. Kawabe, S. Hashimoto, M. Harata, Y. Nitta, and M. Murao Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C Hepatol Res 40 2010 383 392
38. C. Hézode, L. Castera, F. Roudot-Thorval, M. Bouvier-Alias, I. Rosa, and D. Roulot Liver stiffness diminishes with antiviral response in chronic hepatitis C Aliment Pharmacol Ther 34 2011 656 663
39. D. Marouka, F. Imazeki, M. Arai, T. Kanda, K. Fujiwara, and O. Yokosuka Longitudinal changes of the laboratory data of chronic hepatitis C patients with sustained virological response on long-term follow-up J Viral Hepat 19 2012 97 104
40. D. Crisan, D. Radu, M.D. Grigorescu, M. Lupsor, D. Feier, and M. Grigorescu Prospective non-invasive follow-up of liver fibrosis in patients with chronic hepatitis C J Gastrointest Liver Dis 21 2012 375 382
41. C.D. Zois, G.H. Baltayiannis, P. Karayiannis, and E.V. Tsianos Systematic review: hepatic fibrosis - regression with therapy Aliment Pharmacol Ther 28 2008 1175 1187
42. N. Forestier, A. Gaus, E. Herrmann, C. Sarrazin, J. Bojunga, and T. Poynard Acoustic radiation force impulse imaging for evaluation of antivirale treatment response in chronic hepatitis C J Gastrointest Liver Dis 21 2012 367 373